Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)
| Image |  |
|---|---|
| Description | scientific article published on 06 October 2020 |
| Author/s |
author: Darren R Feldman Toni K Choueiri |
| Publication date | October 6, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |